Anti-VEGF Use in Ophthalmology
by Jay S Duker MD (Author), Michelle C. Liang MD (Author)
by Jay S Duker MD (Author), Michelle C. Liang MD (Author)
When it comes to ocular diseases, the introduction of anti-vascular endothelial growth factor (VEGF) agents has truly revolutionized therapy. These agents have proven to be effective in treating a wide range of eye conditions associated with leakage from normal blood vessels and pathologic blood vessel growth. To provide eye care professionals with comprehensive and up-to-date information on the use of these agents, Drs. Jay S. Duker and Michelle C. Liang have collaborated with a prestigious group of contributors to create Anti-VEGF Use in Ophthalmology.
As eye care providers, it is important to understand the history of VEGF and have knowledge of the various anti-VEGF agents and routes of drug delivery. The first section of this book provides an overview of these aspects, ensuring eye care providers are well-informed on the medications and indications for use. The second section goes into detail on the clinical uses of anti-VEGF agents in numerous ocular diseases, providing valuable insights for the treatment of conditions in the anterior segment, cornea and glaucoma, uveitis, and various retinal and choroidal diseases.
This comprehensive book not only combines theory and applications of anti-VEGF agents, but it also utilizes high-quality ocular imaging to demonstrate the therapeutic use of these agents. Each chapter summarizes the disease process and showcases the effectiveness of anti-VEGF agents through these images.
Whether you are a beginner or an experienced eye care professional, Anti-VEGF Use in Ophthalmology is a valuable resource. It serves as a great learning tool for beginners, providing a solid foundation in the use of these agents. For experienced professionals, it serves as a useful reference tool, keeping them up-to-date on the latest advancements and applications.
Some of the topics covered in this book include neovascular age-related macular degeneration, proliferative diabetic retinopathy, retinal vein occlusion, uveitis, neovascular glaucoma, macular edema, retinopathy of prematurity, and corneal disease. With such a wide range of ocular diseases covered, this book is an essential resource for eye care professionals of all specialties, including optometrists, residents, comprehensive ophthalmologists, and specialists in anterior segment, pediatrics, and vitreoretinal diseases.
Anti-VEGF Use in Ophthalmology is available digitally as an eBook. It has a length of 200 pages and is published by Slack Incorporated, with the first edition released on May 15, 2017. The book is written in English and has the ISBN-10: 1630913219 and ISBN-13: 978-1630913212.
Order your copy of Anti-VEGF Use in Ophthalmology today and gain valuable insights into the use of anti-VEGF agents in the treatment of ocular diseases. Whether you are a beginner or an experienced professional, this book will provide you with the knowledge and information you need to provide the best possible care for your patients.
Product Details
- Neovascular Age-Related Macular Degeneration
- Proliferative Diabetic Retinopathy
- Retinal Vein Occlusion
- Uveitis
- Neovascular Glaucoma
- Macular Edema
- Retinopathy of Prematurity
- Corneal Disease
- : 200 pages
- Publisher: Slack Incorporated; 1 edition (May 15, 2017)
- Language: English
- ISBN-10: 1630913219
- ISBN-13: 978-1630913212